Leveraging Cleveland Clinic’s established culture of innovation, transformative research and unmatched clinical talent, Innovations drives patient-centered solutions to the market.
With every innovation, we strive to:
How do our innovations touch lives? Explore a few of our success stories.
In 2020, nurses envisioned a better way to keep IV lines off the floor for pediatric and ICU patients. An innovative system called High-Line™ lets caregivers attach long lines to the wall or ceiling so patients can move around with fewer risks. A color-coded cradle for multiple IV lines helps nurses identify medications more easily. This novel medical device was licensed to Medline® in 2021.
FDA-cleared endovascular navigation technology makes procedures safer, faster and more precise. A GPS-like tracking system reduces radiation exposure, allows intraoperative 3D visualization and provides real-time guidance of catheters and guidewires. In 2021, this technology was used in its first surgical case in the MOTION Clinical Study.
After decades of research, an immunologist at Cleveland Clinic developed a vaccine for triple-negative breast cancer (TNBC). TNBC doesn’t have the same proteins as other types of breast cancer, so fewer effective treatments exist. But a new vaccine targets a specific protein found in TNBC tissue and triggers an immune response to prevent the growth of cancer cells that produce the protein. The vaccine was licensed to Anixa Biosciences®. In 2021, the first FDA-cleared clinical trial began.
Since our inception in 2000, Cleveland Clinic Innovations has a proven track record of excellence:
Contact us to partner or learn more about what we do and why we do it.